Avidity Biosciences (RNA) Stock Price

$31.12 0%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    10
  • Fundamental

    7
  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Avidity Biosciences, AI stock picks, stock alerts and much more.

Sign up

RNA AI Stock Analysis

AI stock analysis for RNA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Avidity Biosciences (RNA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Avidity Biosciences (RNA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Avidity Biosciences (RNA), currently trading at $31.12, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About RNA

LSE
  • Avidity Biosciences, Inc.

  • Symbol

    RNA

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    3.7B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX
$21.62
2%
6
INO Inovio Pharmaceuticals
INO
$2.24
0.9%
2
MRNA Moderna
MRNA
$35.53
5.3%
4
AVXL Anavex Life Sciences
AVXL
$8.35
3.8%
6
BBIO BridgeBio Pharma
BBIO
$36.85
0.1%
6

RNA Alternative Data

Web Traffic

Avidity Biosciences receives an estimated 19083 monthly visitors to aviditybiosciences.com.

  • Web Traffic

    19083

  • Change from Previous Month

    61.4%

  • 3 Month Change

    9%

  • YoY Change

    9%

News Mentions

Avidity Biosciences was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

  • 3 Month Change

    100%

Reddit Mentions

Avidity Biosciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

Twitter Followers

Avidity Biosciences has 712 Twitter Followers on its main Twitter (also known as X) account, which is up by 2% over the last month.

  • Twitter Followers

    712

  • Daily Change

    0%

  • 1 Month Change

    2%

  • 3 Month Change

    1.1%

LinkedIn Followers

21,916 are following Avidity Biosciences on LinkedIn, up by 6.4% over the last month.

  • LinkedIn Followers

    21916

  • Daily Change

    0.2%

  • 1 Month Change

    6.4%

  • 3 Month Change

    14.1%

Job Postings

Avidity Biosciences currenly has an estimated 43 open job postings, up by 34.4% over the last month.

  • Job Postings

    43

  • Daily Change

    4.4%

  • 1 Month Change

    34.4%

  • 3 Month Change

    24.6%

LinkedIn Employees

According to LinkedIn, Avidity Biosciences has 387 employees, up by 2.1% over the last month.

  • LinkedIn Employees

    387

  • Daily Change

    0%

  • 1 Month Change

    2.1%

  • 3 Month Change

    11.8%

Business Outlook
  • Business Outlook

    82

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

RNA Financials

RNA Key Metrics
  • Total Revenue

    $2.3M

  • Net Income

    -$80.4M

  • Earnings per Share

    -$0.65

  • Free cash flow

    -$67.3M

  • EBITDA

    -$97.4M

  • EBITDA Ratio

    -41.7055

  • Total Assets

    $1.6B

RNA 2-year Revenue & Income
RNA 2-year Free Cash Flow

RNA Technicals

RNA SMA
RNA RSI

FAQ

What's the current price of Avidity Biosciences (RNA) Stock?
The price of an Avidity Biosciences (RNA) share is $31.12.

What's the market cap of Avidity Biosciences?
The current market cap of Avidity Biosciences is 3.7B.

Should I buy or sell RNA?
Multiple alternative data signals suggest that Avidity Biosciences stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.

Is Avidity Biosciences a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Avidity Biosciences stock. The bullish indicators suggest that Avidity Biosciences' growth prospects and market position may lead to a positive performance in the foreseeable future.

Is now a good time to buy Avidity Biosciences (RNA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Avidity Biosciences stock, given the bullish outlook.

What are some stocks similar to Avidity Biosciences (RNA) that investors often compare it to?
Avidity Biosciences (RNA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Avidity Biosciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Avidity Biosciences' stock price to be around $33.92 in 2026. Starting from the current price of $31.12, this represents a 9% change in price, indicating a bullish outlook for the stock.

How to buy Avidity Biosciences (RNA) Stock?
Avidity Biosciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Avidity Biosciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.